查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1999072

神經外科醫療設備市場：依產品類型、手術方法、最終用戶和應用分類－2026-2032年全球市場預測

Neurosurgery Devices Market by Product Type, Procedure, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，神經外科醫療設備市場價值將達到 149.1 億美元，到 2026 年將成長至 169.2 億美元，到 2032 年將達到 376.4 億美元，複合年成長率為 14.13%。

主要市場統計數據
基準年 2025 149.1億美元
預計年份：2026年 169.2億美元
預測年份：2032年 376.4億美元
複合年成長率 (%) 14.13%

對神經外科醫療設備進行全面概述，重點在於技術融合、臨床應用壓力、監管變化及其對策略決策的影響。

隨著技術創新與醫療服務模式的變革以及臨床期望的不斷提高相融合，神經外科醫療設備的研發正在加速發展。該領域如今涵蓋了從生物活性植入材料和先進植入系統到高清內視鏡和導航平台等眾多方面，這些設備能夠實現精準手術。同時，臨床實踐正朝著微創方向發展，醫療系統在實施相關技術之前，需要獲得充分的安全性、有效性和經濟價值的證據。這些趨勢正在重塑採購政策、臨床工作流程以及製造商和供應商的競爭格局。

分析技術創新、臨床實務變革、監管加強和商業性結構調整如何重塑神經外科醫療設備的開發和部署。

神經外科醫療設備領域正經歷一系列變革，涵蓋技術、臨床、監管和商業性等多個面向。在技​​術層面，成像、電磁和光學導航以及微型內視鏡的進步，使外科醫生能夠更精準地進行手術，並減少對周圍組織的損傷。除了這些改進之外，旨在改善骨癒合和神經組織相容性的植入材料和生物假體的進步，也正在提升患者的長期療效。機器人輔助和人工智慧驅動的影像引導技術正從實驗階段走向實用化，從而降低複雜手術的差異性，並縮短訓練週期。

評估關稅引起的成本壓力和供應鏈調整如何改變了神經外科醫療設備製造商的籌資策略、產品設計選擇和商業化時間表。

2025年實施的新關稅措施引發了整個神經外科醫療設備生態系統的一系列營運和策略性應變措施。依賴國際供應鏈的製造商面臨零組件和成品採購成本上升的困境，這給其利潤率結構和定價策略帶來了壓力。為此，許多企業採取了短期戰術措施，以降低對單一國家供應的依賴風險，例如重新調整生產批次的優先順序、增加關鍵零件的庫存緩衝以及加快雙戰術性認證。從稍長遠的觀點來看，關稅環境正在促使企業重新評估製造地的地理位置，從而更加重視將生產遷回國內以及多元化發展至其他成本更低的製造地區。

以細分主導的臨床和商業情報，將產品子類別、最終用戶環境、應用和治療類型聯繫起來，優先考慮創新和市場進入方案。

細分市場分析揭示了不同產品類別、終端用戶、臨床應用和治療方法中存在的細微機會和營運需求。產品類型細分包括生物製劑、內視鏡、植入式設備、儀器、導航系統和神經刺激設備。在生物製劑領域，骨移植和生長因子日益受到關注，凸顯了對能夠與宿主組織整合並降低再次手術風險的材料的需求。這促使研發人員優先考慮生物活性、滅菌相容性和供應鏈可追溯性。內視鏡分為軟式內視鏡內視鏡和硬式內視鏡，二者的應用模式各不相同。軟式內視鏡在彎曲的解剖結構和門診手術中應用越來越廣泛，而硬式內視鏡由於其影像穩定性，在某些顱內和脊椎手術中仍然是首選。植入式醫療器材可細分為顱腦植入物和脊椎移植，其中顱腦植入又包括顱骨板和硬腦膜替代物，脊椎移植則包括融合器和椎弓骨釘。本文的研究結果強調了植入的生物相容性、模組化和易於固定對於縮短手術時間和降低併發症發生率的重要性。臨床團隊正在評估包括鑽頭、穿孔器、牽開器系統和超音波吸引器在內的各種手術器械的人體工學設計、消毒流程以及與微創手術的兼容性。導航系統分為電磁平台和光學平台，需要精確定位並與成像系統互通性。神經刺激設備分為深部腦部刺激器和迷走神經刺激設備，其發展得益於導線技術的改進和封閉回路型編程選項的增加，從而支持更廣泛的治療適應症。

對臨床基礎設施、監管細微差別、採購趨勢和策略方法進行區域比較評估，以加快在全球主要地區的部署。

區域趨勢正在影響商業機會和產業計畫，美洲、歐洲、中東和非洲以及亞太地區的優先事項各不相同。在美洲，一體化醫療保健系統和先進的門診手術中心網路正在催生對能夠在各種醫療保健環境中展現出明確經濟和臨床價值的醫療設備的需求。該地區的監管流程日益符合上市後證據的要求，要求製造商投資於註冊登記和結果追蹤。歐洲、中東和非洲的市場環境各不相同，在報銷機制、醫院採購實務和臨床基礎設施方面存在顯著的區域差異。希望在市場站穩腳跟的製造商必須根據各國的醫療技術評估流程調整打入市場策略，並與當地臨床領導者合作克服推廣障礙。在亞太地區，醫院基礎設施的快速擴張、神經外科手術的增加以及政府主導的醫療保健系統投資正在推動對高度可擴展的醫療設備解決方案和本地製造夥伴關係關係的需求。在所有地區，供應鏈韌性、協調法規的努力以及數位整合能力都是影響採購決策和長期夥伴關係的差異化因素。

本書探討了整合平台、專業創新者和契約製造方案如何影響產品開發和業務擴張，並研究了企業策略行動和夥伴關係模式。

從公司層面來看，趨勢揭示了一個競爭格局：成熟的醫療技術公司、專注於特定設備的專業公司以及創新Start-Ups，都在塑造神經外科醫學的未來方面發揮著各自獨特的作用。主要企業正投資於平台策略，整合硬體、軟體和資訊服務，建立整合解決方案，以減少臨床差異並實現可衡量的療效。同時，專注於特定領域的專業公司和新興企業正在推動“點創新”，例如突破性的生技藥品、精密的植入設計或新一代刺激導線，這些創新旨在解決特定的臨床難題，並使它們成為極具吸引力的合作和收購目標。

實用、跨產業的指導，用於產品開發、供應鏈彈性、證據產生和商業化，以確保永續採用和競爭優勢。

產業領導企業應採取優先排序的跨部門方法，將產品創新與實證實踐、供應鏈韌性和以客戶為中心的商業化相結合。首先，在研發週期的早期階段就應整合臨床證據規劃，確保臨床試驗、註冊登記和真實世界資料收集能夠滿足外科醫生、保險公司和採購者的關鍵需求。這種前瞻性的方法可以縮短商業化時間，並增強醫保報銷的競爭力。其次，應重新設計供應鏈策略，減少對單一供應商的依賴，並在關稅風險和物流中斷可能顯著影響手術時間的地區探索本地生產和雙重採購模式。投資於供應商合格和材料工程可以帶來永續的成本和品質優勢。

採用透明的混合方法研究途徑，結合對從業人員的訪談、臨床文獻、監管審查和情境分析，得出可靠的結論。

本摘要總結的研究結果是基於一種混合研究方法，該方法結合了定性專家訪談、針對臨床醫生和採購經理的定向一手調查，以及對臨床文獻和監管文件的嚴謹二手研究。一手數據包括對神經外科醫生、手術室管理人員、醫院採購負責人、醫療設備工程師和衛生經濟學專家的結構化訪談，旨在了解臨床優先事項和採購趨勢。這些觀點與同行評審的臨床研究、醫療設備註冊資訊和公開的監管文件進行交叉比對，以檢驗臨床性能聲明、安全性概況和上市後義務。

整合策略挑戰和風險因素，以決定哪些組織能夠成功推動神經外科護理的臨床應用和商業性規模化。

神經外科醫療設備生態系統正處於轉折點，技術、臨床需求、監管預期和地緣政治因素相互交織，迫使投資和實施重點進行重組。能夠將差異化醫療設備能力與嚴謹的證據產生、穩健的供應鏈以及針對特定臨床和區域環境量身定做的商業化策略相結合的企業，將擁有廣闊的發展機會。反之，未能應對關稅驅動的成本波動、日益嚴格的監管以及對可驗證療效日益成長的需求的企業，則可能面臨產品推廣延遲和商業性回報減少的風險。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：神經外科醫療設備市場：依產品類型分類

  • 生技藥品
    • 骨移植材料
    • 生長因子
  • 內視鏡
    • 軟性內視鏡
    • 硬式內視鏡
  • 植入式醫療設備
    • 顱骨植入
      • 顱骨板
      • 杜拉爾替代材料
    • 脊椎移植
      • 固定籠
      • 椎弓骨釘
  • 裝置
    • 鑽頭和穿孔器
    • 牽開器系統
    • 超音波吸引器
  • 導航系統
    • 電磁系統
    • 光學系統
  • 神經刺激設備
    • 深部腦部刺激器
    • 迷走神經刺激設備

第9章：神經外科醫療設備市場：依手術方法分類

  • 內視鏡手術
  • 雷射治療
  • 微創手術
  • 開放性手術

第10章：神經外科醫療設備市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 研究機構
  • 專科診所

第11章 神經外科醫療設備市場：依應用領域分類

  • 腦腫瘤
  • 癲癇
  • 水腦症
  • 運動障礙
  • 疼痛管理
  • 脊髓疾病

第12章 神經外科醫療設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 神經外科醫療設備市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 神經外科醫療設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國神經外科醫療設備市場

第16章：中國神經外科醫療設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Globus Medical, Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Medtronic plc
  • Penumbra, Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Terumo Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-E370886767D8

The Neurosurgery Devices Market was valued at USD 14.91 billion in 2025 and is projected to grow to USD 16.92 billion in 2026, with a CAGR of 14.13%, reaching USD 37.64 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 14.91 billion
Estimated Year [2026] USD 16.92 billion
Forecast Year [2032] USD 37.64 billion
CAGR (%) 14.13%

Comprehensive orientation to neurosurgery devices highlighting technological convergence, clinical adoption pressures, regulatory evolution and implications for strategic decision-making

Neurosurgery device development is advancing at an accelerated pace as technological innovation converges with changing care delivery models and heightened clinical expectations. The field now spans a spectrum from biologically active graft materials and sophisticated implantable systems to high-definition endoscopes and navigation platforms that enable precision procedures. Concurrently, clinical practice is shifting toward less invasive approaches, and health systems are demanding robust evidence of safety, efficacy, and economic value before adoption. These dynamics are reshaping procurement preferences, clinical workflows, and competitive positioning for manufacturers and suppliers.

In parallel, regulatory frameworks and payer expectations are emphasizing real-world outcomes and post-market surveillance, which increases the importance of integrated data capture and longitudinal clinical studies. Investors are responding by favoring companies that demonstrate not only technical differentiation but also reproducible clinical benefits and credible commercialization pathways. As a result, product roadmaps are being designed with modularity and interoperability in mind, anticipating integration with navigation systems, neurostimulation platforms, and digital clinical decision support.

This introduction sets the stage for an analysis that interlinks clinical trends, device innovation, end-user behavior, and broader geopolitical and regulatory shifts. The following sections examine transformative changes in the landscape, tariff-driven operational impacts, segmentation-specific insights, regional dynamics, competitive behaviors, actionable recommendations, research methodology, and concluding implications for leaders shaping the future of neurosurgical care.

Analysis of converging technological innovations, clinical practice shifts, regulatory tightening, and commercial realignments reshaping neurosurgery device development and adoption

The neurosurgery device landscape is undergoing a set of transformative shifts that are simultaneously technological, clinical, regulatory, and commercial. On the technological front, advances in imaging, electromagnetic and optical navigation, and miniaturized endoscopy are enabling surgeons to operate with greater precision and reduced collateral tissue damage. These improvements are complemented by refinements in implant materials and biologic adjuncts designed to enhance bone healing and neural tissue compatibility, thereby improving long-term patient outcomes. Robotic assistance and AI-enabled image guidance are moving from experimental to pragmatic tools that reduce variability and shorten learning curves for complex procedures.

Clinically, the movement toward minimally invasive techniques and outpatient settings is changing procedural mixes and driving demand for instruments and devices that support shorter procedure times and rapid recovery. Neurostimulation technologies, particularly deep brain and vagus nerve stimulation, are expanding indications and seeing renewed interest as understanding of neuromodulation mechanisms deepens. Simultaneously, an increased emphasis on patient-reported outcomes and quality metrics is raising the bar for clinical evidence required to support adoption and reimbursement.

Regulatory and reimbursement landscapes are also shifting, with agencies requiring more comprehensive post-market data and payers looking for demonstrable value in terms of reduced complications, shorter hospital stays, and improved functional outcomes. On the commercial side, partnerships between established medtech firms, specialty device innovators, and clinical research networks are accelerating product translation while changing competitive dynamics. Taken together, these shifts create both opportunities and elevated execution risk for companies that must align product innovation with clinical utility and regulatory rigor.

Evaluation of how tariff-driven cost pressures and supply chain adjustments have reshaped sourcing strategies, product design choices, and commercialization timelines across neurosurgical device makers

The implementation of new tariff measures in the United States during 2025 has prompted a cumulative set of operational and strategic responses across the neurosurgery devices ecosystem. Manufacturers that rely on international supply chains have confronted increased landed costs for components and finished goods, which in turn pressures margin structures and pricing strategies. In response, many organizations initiated near-term tactical measures such as reprioritizing production runs, increasing inventory buffers for critical components, and accelerating dual-source qualification to reduce exposure to single-country supply dependencies. Over a slightly longer horizon, the tariff environment has encouraged a reevaluation of geographic manufacturing footprints, with increased consideration of reshoring or diversification into alternative low-cost manufacturing regions.

Beyond direct cost effects, tariffs have affected partner selection, contract negotiation, and capital allocation decisions. Procurement teams are renegotiating supplier agreements to incorporate tariff pass-through clauses and to obtain more favorable lead times and quality guarantees. Strategic teams are revisiting product designs to simplify bill-of-materials complexity, reduce reliance on tariff-sensitive components, and explore material substitutions that maintain clinical performance while mitigating cost risk. Clinical and regulatory teams are also involved, since design changes can trigger additional validation work and regulatory submissions, thereby affecting time-to-market.

Moreover, the tariff-induced dynamics have had downstream effects on clinical adoption timelines and health system purchasing behavior, as providers factor in potential supply volatility and total cost of ownership when evaluating new devices. Investors and corporate development groups are likewise recalibrating valuation models and partnership timelines to reflect the heightened operational uncertainty. Overall, the cumulative impact of the tariff changes has accelerated supply chain modernization efforts and heightened the importance of resilient, compliant, and clinically focused commercialization strategies.

Segmentation-driven clinical and commercial intelligence linking product subcategories, end-user settings, applications, and procedure types to prioritize innovation and market entry choices

Segmentation analysis reveals nuanced opportunities and execution imperatives across product classes, end users, clinical applications, and procedural approaches. Product type segmentation spans biologics, endoscopes, implantable devices, instruments, navigation systems, and neurostimulators. Within biologics, the focus on bone grafts and growth factors highlights a demand for materials that integrate with host tissue and reduce revision risk, prompting developers to prioritize bioactivity, sterilization compatibility, and supply chain traceability. Endoscopes, differentiated into flexible and rigid designs, show distinct adoption patterns: flexible endoscopes are gaining traction in tortuous anatomy and outpatient procedures, while rigid endoscopes continue to be preferred for certain intracranial and spinal exposures due to image stability. Implantable devices subdivide into cranial and spinal implants, with cranial implants further segmented into cranial plates and dural substitutes and spinal implants emphasizing fusion cages and pedicle screws; insights here underscore the premium on implant biocompatibility, modularity, and ease of fixation to reduce operative time and complication rates. Instruments, encompassing drills and perforators, retractor systems, and ultrasonic aspirators, are being evaluated by clinical teams for ergonomics, sterilization cycles, and compatibility with minimally invasive access. Navigation systems, split between electromagnetic and optical platforms, must deliver registration accuracy and interoperability with imaging suites. Neurostimulators, categorized into deep brain stimulators and vagus nerve stimulators, are advancing through refined lead technologies and closed-loop programming options that support expanded therapeutic indications.

End user segmentation includes ambulatory surgical centers, hospitals, research institutes, and specialty clinics. Ambulatory surgical centers are driving demand for compact, cost-effective devices that enable same-day discharge, whereas hospitals prioritize systems that integrate with existing imaging and monitoring infrastructure and support complex case mixes. Research institutes and specialty clinics serve as early adopters, providing clinical evidence and proof-of-concept data that can accelerate broader adoption.

Application segmentation covers brain tumors, epilepsy, hydrocephalus, movement disorders, pain management, and spinal cord disorders. Each application imposes distinct clinical performance requirements, ranging from precision resection margins for oncologic procedures to long-term stimulation durability for movement and pain indications. Procedure segmentation encompasses endoscopic surgery, laser therapy, minimally invasive surgery, and open surgery, and these procedural contexts determine device form factors, sterilization regimens, and instrument sets. Synthesizing these segmentation lenses highlights where clinical unmet needs intersect with technological capability and where targeted evidence generation and commercialization investments will deliver highest impact.

Comparative regional assessment of clinical infrastructure, regulatory nuance, procurement behavior, and strategic pathways to accelerate adoption across major global territories

Regional dynamics are shaping both opportunity and operational planning, with distinct priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, consolidated health systems and progressive ambulatory surgical center networks are creating demand for devices that demonstrate clear economic and clinical value across diverse care settings. Regulatory pathways in the region are increasingly aligned with post-market evidence expectations, requiring manufacturers to invest in registries and outcomes tracking. The Europe, Middle East & Africa region presents a heterogeneous landscape where reimbursement mechanisms, hospital procurement practices, and clinical infrastructure vary widely; manufacturers seeking traction must tailor market access strategies to national health technology assessment processes and engage local clinical champions to navigate adoption barriers. In the Asia-Pacific region, rapid hospital infrastructure expansion, growing neurosurgical caseloads, and government-led investment in healthcare capacity are driving demand for scalable device solutions and localized manufacturing partnerships. Across all regions, supply chain resilience, regulatory harmonization efforts, and digital integration capabilities are differentiators that influence both purchasing decisions and long-term partnerships.

Transnational considerations further complicate regional strategies. Cross-border clinical trials, regulatory equivalence initiatives, and multiregional reimbursement pilots can accelerate global launches but require careful orchestration of regulatory filings, clinical evidence packages, and training programs. Manufacturers that design regional rollouts to leverage center-of-excellence partnerships, digital training platforms, and adaptive pricing structures are better positioned to translate early clinical uptake into sustained adoption and favorable procurement terms.

Strategic company behaviors and partnership models revealing how integrated platforms, specialty innovators, and contract manufacturing choices influence commercialization and scaling

Company-level behaviors reveal a competitive landscape where established medtech firms, focused device specialists, and innovative startups each play distinct roles in shaping the trajectory of neurosurgical care. Leading firms are investing in platform strategies that bundle hardware, software, and data services to create integrated solutions that lower clinical variability and provide measurable outcomes. At the same time, focused specialists and emerging companies are advancing point innovations-novel biologics, refined implant designs, or next-generation stimulation leads-that address specific clinical gaps and can be attractive targets for partnership or acquisition.

Across the ecosystem, commercialization strategies emphasize evidence generation, clinician training, and service models that support device uptime and clinical outcomes. Strategic partnerships between device manufacturers, imaging and navigation vendors, and academic centers are accelerating product validation and clinician endorsement. Manufacturing partners and contract service providers are also central to scalability, particularly for companies that elect to regionalize production to mitigate tariff and logistics risks. Additionally, firms that prioritize transparent pricing, robust post-market surveillance, and clear interoperability standards are finding smoother pathways into health system procurement processes. In aggregate, company insights point to a bifurcated market where platform incumbents focus on integrated solutions and specialty innovators pursue clinical differentiation, both needing disciplined execution across regulatory, clinical, and commercial dimensions.

Actionable cross-functional guidance for product development, supply resilience, evidence generation, and commercialization to secure durable adoption and competitive advantage

Industry leaders should take a prioritized, cross-functional approach that aligns product innovation with evidence generation, supply resilience, and customer-centric commercialization. First, embed clinical evidence planning early in development cycles so that trials, registries, and real-world data capture address the endpoints that matter to surgeons, payers, and purchasers. This anticipatory approach shortens commercialization timelines and enhances reimbursement positioning. Next, redesign supply chain strategies to reduce single-source exposure and to evaluate regional manufacturing or dual-sourcing where tariff risk or logistics disruption could materially affect time-to-surgery. Investing in supplier qualification and materials engineering can yield durable cost and quality advantages.

Commercially, tailor value propositions to specific end-user segments: ambulatory surgical centers seek compact, cost-effective solutions; hospitals demand interoperability and service reliability; specialty clinics value clinical performance and training. Develop modular platforms and compatible instrument ecosystems to reduce procurement friction and to enable incremental upgrades rather than wholesale replacements. Operationally, expand clinician training programs through digital simulation and proctoring models to accelerate surgeon proficiency and to capture early outcome data. Regulatory and quality teams should prepare for iterative submissions by documenting post-market surveillance plans and by building electronic data capture processes that support compliance with regional requirements.

Finally, pursue alliances that complement internal capabilities, whether for advanced navigation, biologic manufacturing, or clinical research networks. Prioritize commercial pilots with high-impact centers that can produce reproducible outcomes and serve as reference accounts. By executing on these recommendations, leaders can improve the odds of durable adoption and create defensible competitive positioning in a dynamic neurosurgical device landscape.

Transparent mixed-methods research approach integrating practitioner interviews, clinical literature, regulatory review, and scenario analysis to underpin robust conclusions

The findings synthesized in this summary are grounded in a mixed-methods research approach that combined qualitative expert interviews, targeted primary research with clinicians and purchasing leaders, and rigorous secondary analysis of clinical literature and regulatory documentation. Primary inputs included structured interviews with neurosurgeons, operating room managers, hospital procurement specialists, device engineers, and health economics experts to capture both clinical priorities and procurement dynamics. These perspectives were triangulated with peer-reviewed clinical studies, device registries, and public regulatory filings to validate clinical performance claims, safety profiles, and post-market obligations.

Analytical methods included thematic synthesis to identify principal clinical and commercial trends, scenario analysis to evaluate the operational impacts of tariff changes and supply chain disruptions, and segmentation mapping to align device attributes with end-user needs and procedural contexts. Quality assurance protocols ensured that all claims were corroborated by more than one source and that conflicting inputs were reconciled through follow-up interviews or sensitivity checks. Ethical and compliance considerations governed the handling of primary data, and anonymized summaries of interview findings were used to protect confidentiality while preserving the richness of practitioner insight.

This methodological framework supports robust, actionable conclusions by integrating practitioner insight with documentary evidence and by explicitly addressing areas of uncertainty through scenario planning and sensitivity assessment.

Synthesis of strategic imperatives and risk considerations that will determine which organizations succeed in advancing clinical adoption and commercial scale in neurosurgical care

The neurosurgery devices ecosystem sits at an inflection point where technology, clinical demand, regulatory expectations, and geopolitical factors converge to reshape investment and execution priorities. Opportunities are abundant for organizations that can align differentiated device capabilities with rigorous evidence generation, resilient supply chains, and tailored commercialization strategies for specific clinical and regional contexts. Conversely, companies that fail to plan for tariff-induced cost volatility, regulatory rigor, and the increasing demand for demonstrable outcomes risk slower adoption and eroded commercial returns.

Leaders should focus on building interoperable platforms, investing in clinician training and real-world evidence programs, and structuring supply chains to minimize disruption risk. Strategic partnerships and targeted M&A can accelerate access to complementary technologies and clinical channels, while prudent product design choices can reduce total cost of ownership for providers. Ultimately, success in this market will favor organizations that take a systems-thinking approach, integrating engineering excellence with clinical validation and adaptive commercialization models that reflect the realities of care delivery across regions and provider types.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Neurosurgery Devices Market, by Product Type

  • 8.1. Biologics
    • 8.1.1. Bone Grafts
    • 8.1.2. Growth Factors
  • 8.2. Endoscopes
    • 8.2.1. Flexible Endoscopes
    • 8.2.2. Rigid Endoscopes
  • 8.3. Implantable Devices
    • 8.3.1. Cranial Implants
      • 8.3.1.1. Cranial Plates
      • 8.3.1.2. Dural Substitutes
    • 8.3.2. Spinal Implants
      • 8.3.2.1. Fusion Cages
      • 8.3.2.2. Pedicle Screws
  • 8.4. Instruments
    • 8.4.1. Drills And Perforators
    • 8.4.2. Retractor Systems
    • 8.4.3. Ultrasonic Aspirators
  • 8.5. Navigation Systems
    • 8.5.1. Electromagnetic Systems
    • 8.5.2. Optical Systems
  • 8.6. Neurostimulators
    • 8.6.1. Deep Brain Stimulators
    • 8.6.2. Vagus Nerve Stimulators

9. Neurosurgery Devices Market, by Procedure

  • 9.1. Endoscopic Surgery
  • 9.2. Laser Therapy
  • 9.3. Minimally Invasive Surgery
  • 9.4. Open Surgery

10. Neurosurgery Devices Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Hospitals
  • 10.3. Research Institutes
  • 10.4. Specialty Clinics

11. Neurosurgery Devices Market, by Application

  • 11.1. Brain Tumors
  • 11.2. Epilepsy
  • 11.3. Hydrocephalus
  • 11.4. Movement Disorders
  • 11.5. Pain Management
  • 11.6. Spinal Cord Disorders

12. Neurosurgery Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Neurosurgery Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Neurosurgery Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Neurosurgery Devices Market

16. China Neurosurgery Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. B. Braun Melsungen AG
  • 17.7. Boston Scientific Corporation
  • 17.8. Globus Medical, Inc.
  • 17.9. Integra LifeSciences Holdings Corporation
  • 17.10. Johnson & Johnson
  • 17.11. Medtronic plc
  • 17.12. Penumbra, Inc.
  • 17.13. Smith & Nephew plc
  • 17.14. Stryker Corporation
  • 17.15. Terumo Corporation
  • 17.16. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEUROSURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NEUROSURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BONE GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BONE GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BONE GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROWTH FACTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROWTH FACTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL PLATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL PLATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL PLATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DURAL SUBSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DURAL SUBSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DURAL SUBSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FUSION CAGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FUSION CAGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY FUSION CAGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PEDICLE SCREWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PEDICLE SCREWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PEDICLE SCREWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DRILLS AND PERFORATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DRILLS AND PERFORATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DRILLS AND PERFORATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RETRACTOR SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RETRACTOR SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RETRACTOR SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPTICAL SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPTICAL SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPTICAL SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY LASER THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY LASER THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BRAIN TUMORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BRAIN TUMORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY BRAIN TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY EPILEPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY EPILEPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HYDROCEPHALUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HYDROCEPHALUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY HYDROCEPHALUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MOVEMENT DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MOVEMENT DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY MOVEMENT DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL CORD DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL CORD DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL CORD DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. GCC NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 245. GCC NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. GCC NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 247. GCC NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 248. GCC NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 249. GCC NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 250. GCC NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 251. GCC NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 252. GCC NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 253. GCC NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 254. GCC NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 255. GCC NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. GCC NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 278. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 283. G7 NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 284. G7 NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. G7 NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 286. G7 NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 287. G7 NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 288. G7 NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 289. G7 NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 290. G7 NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 291. G7 NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 292. G7 NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 293. G7 NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 294. G7 NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 295. G7 NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 296. NATO NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 297. NATO NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. NATO NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 299. NATO NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 300. NATO NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 301. NATO NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 302. NATO NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 303. NATO NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 304. NATO NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 305. NATO NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 306. NATO NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 307. NATO NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 308. NATO NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 309. GLOBAL NEUROSURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY CRANIAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY SPINAL IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 321. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 322. UNITED STATES NEUROSURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 323. CHINA NEUROSURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 324. CHINA NEUROSURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 325. CHINA NEUROSURGERY DEVICES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 326. CHINA NEUROSURGERY DEVICES MARKET SIZE, BY ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 327. CHINA NEUROSURGERY DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 328. CHINA NEUROSURGERY DEVICES MARKET SIZE, BY CR